Skip to main content
Caplight Logo









Autoscriber

Autoscriber

Private
EindhovenHealthcare & Life Scienceshttps://autoscriber.com/

Last Round

Seed

Jan 11, 2023

Total Funding Raised

$1.29M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Autoscriber is a healthcare IT company that provides AI-powered software to transcribe and summarize doctor-patient conversations into structured clinical notes.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Medical AI, NLP & Conversational AI, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

ambient clinical intelligenceAI medical scribeautomated clinical documentationclinical intelligence platformambient listeningEHR integrationmedical transcription AIclinical summarizationnatural language processingNLPspeech recognitionmedical codingstructured EHR notesSNOMED-CTICD-10B2B SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Autoscriber Comparables

Compare Autoscriber with similar companies based on industry and business-model similarity.

Autoscriber comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noteless
92%
Tortus
91%
Delphyr
89%

Autoscriber Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 11, 2023
Pre SeedSep 7, 2021

Key People

Founding team and executive leadership

Jacqueline Kazmaier

Cofounder CEO

Founding Team

Danny van Rijn

Chief Operating Officer, Chief Operating Officer

Executive Team

Rik Matena

Chief Product Officer

Executive Team

Autoscriber Investors

Notable investors and investment history

Autoscriber investors
InvestorRounds
Brabantse Ontwikkelings MaatschappijSeed
LUMO LabsSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 11, 61% of headcount.

  • Jul 20, 2026

    Open roles increased to 11, 61% of headcount.

Autoscriber Filings

Explore SEC and related filing metadata, where available.

Autoscriber filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Autoscriber's valuation, stock price, and market status.

Is Autoscriber a public or private company?

Autoscriber is a private company.

What is the current stock price of Autoscriber?

Autoscriber is a private company with no public stock price. No recent secondary market data is available.

How much is Autoscriber worth (valuation)?

Valuation information for Autoscriber is not publicly available.

Can I buy Autoscriber stock?

Autoscriber shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Autoscriber's last funding round?

Autoscriber's most recent funding round was Seed on January 11, 2023.

Who are the main investors in Autoscriber?

Key investors in Autoscriber include LUMO Labs.

Will Autoscriber IPO soon?

No public IPO plans have been announced for Autoscriber.

How can I track Autoscriber secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Autoscriber's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEindhoven
Employee Range16
Year Founded2021
Last FundingJan 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?